Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 12,686 | 4,065 | 3,440 | 4,682 | 4,350 |
| Gross Profit | 12,686 | 4,065 | 3,440 | 4,682 | 4,350 |
| Operating Expenses | 24,444 | 62,203 | 17,860 | 22,688 | 15,559 |
| Operating Income | -11,758 | -58,138 | -14,420 | -18,006 | -11,209 |
| Other Income | 5,505 | 13,960 | -466 | 6,017 | 5,041 |
| Pre-tax Income | -6,253 | -44,178 | -14,886 | -11,989 | -6,168 |
| Income Tax | -989 | -15,196 | N/A | N/A | N/A |
| Net Income Continuous | -5,264 | -28,982 | -14,886 | -11,989 | -6,168 |
| Net Income | $-5,264 | $-28,982 | $-14,886 | $-11,989 | $-6,168 |
| EPS Basic Total Ops | -0.10 | -0.57 | -0.27 | -0.40 | -0.22 |
| EPS Basic Continuous Ops | -0.10 | -0.57 | -0.27 | -0.40 | -0.23 |
| EPS Diluted Total Ops | -0.10 | -0.57 | -0.27 | -0.40 | -0.22 |
| EPS Diluted Continuous Ops | -0.10 | -0.57 | -0.27 | -0.40 | -0.23 |
| EBITDA(a) | $-10,572 | $-19,995 | $-14,273 | $-17,886 | $-11,096 |